170 related articles for article (PubMed ID: 35521682)
41. Inhibition of Heat Shock Factor 1 Enhances Repressive Molecular Mechanisms on the POMC Promoter.
Ciato D; Li R; Monteserin Garcia JL; Papst L; D'Annunzio S; Hristov M; Tichomirowa MA; Belaya Z; Rozhinskaya L; Buchfelder M; Theodoropoulou M; Paez-Pereda M; Stalla GK
Neuroendocrinology; 2019; 109(4):362-373. PubMed ID: 30995664
[TBL] [Abstract][Full Text] [Related]
42. Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions.
Dufner A; Knobeloch KP
Biochem Soc Trans; 2019 Dec; 47(6):1867-1879. PubMed ID: 31845722
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells.
Jian FF; Li YF; Chen YF; Jiang H; Chen X; Zheng LL; Zhao Y; Wang WQ; Ning G; Bian LG; Sun QF
Chin Med J (Engl); 2016 Sep; 129(17):2102-8. PubMed ID: 27569239
[TBL] [Abstract][Full Text] [Related]
44. Germline USP8 Mutation Associated With Pediatric Cushing Disease and Other Clinical Features: A New Syndrome.
Cohen M; Persky R; Stegemann R; Hernández-RamÃrez LC; Zeltser D; Lodish MB; Chen A; Keil MF; Tatsi C; Faucz FR; Buchner DA; Stratakis CA; Tiosano D
J Clin Endocrinol Metab; 2019 Oct; 104(10):4676-4682. PubMed ID: 31162547
[TBL] [Abstract][Full Text] [Related]
45. Aberrant Nuclear Translocation of E2F1 and Its Association in Cushing's Disease.
Araki T; Wang J; Lawrence R; Kawakami Y
Endocrinology; 2022 Aug; 163(8):. PubMed ID: 35678423
[TBL] [Abstract][Full Text] [Related]
46. Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report.
Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
[TBL] [Abstract][Full Text] [Related]
47. Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.
Sbiera S; Tryfonidou MA; Weigand I; Grinwis GC; Broeckx B; Herterich S; Allolio B; Deutschbein T; Fassnacht M; Meij BP
PLoS One; 2016; 11(12):e0169009. PubMed ID: 28005997
[TBL] [Abstract][Full Text] [Related]
48. Targeting the ERK pathway for the treatment of Cushing's disease.
Zhang D; Bergsneider M; Wang MB; Heaney AP
Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
50. New Molecular Targets for Treatment of Cushing's Disease.
Foulkes E; Newell-Price J
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):367-373. PubMed ID: 29754637
[TBL] [Abstract][Full Text] [Related]
51. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
52. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of heat shock protein 90 decreases ACTH production and cell proliferation in AtT-20 cells.
Sugiyama A; Kageyama K; Murasawa S; Ishigame N; Niioka K; Daimon M
Pituitary; 2015 Aug; 18(4):542-53. PubMed ID: 25280813
[TBL] [Abstract][Full Text] [Related]
54. Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.
Lu J; Chatain GP; Bugarini A; Wang X; Maric D; Walbridge S; Zhuang Z; Chittiboina P
J Clin Endocrinol Metab; 2017 Aug; 102(8):2825-2835. PubMed ID: 28505327
[TBL] [Abstract][Full Text] [Related]
55. A heterozygous germline deletion within USP8 causes severe neurodevelopmental delay with multiorgan abnormalities.
Sakamoto M; Kurosawa K; Tanoue K; Iwama K; Ishida F; Watanabe Y; Okamoto N; Tsuchida N; Uchiyama Y; Koshimizu E; Fujita A; Misawa K; Miyatake S; Mizuguchi T; Matsumoto N
J Hum Genet; 2024 Feb; 69(2):85-90. PubMed ID: 38030753
[TBL] [Abstract][Full Text] [Related]
56. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
[TBL] [Abstract][Full Text] [Related]
57. A long-term prognosis study of human USP8-mutated ACTH-secreting pituitary neuroendocrine tumours.
Miao H; Wang L; Gong F; Duan L; Wang L; Yao Y; Feng M; Deng K; Wang R; Xiao Y; Ling Q; Zhu H; Lu L
Clin Endocrinol (Oxf); 2024 Jul; 101(1):32-41. PubMed ID: 38691659
[TBL] [Abstract][Full Text] [Related]
58. Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells.
Hagiwara R; Kageyama K; Niioka K; Takayasu S; Tasso M; Daimon M
Peptides; 2021 Feb; 136():170441. PubMed ID: 33181265
[TBL] [Abstract][Full Text] [Related]
59. Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells.
Xia L; Shen D; Zhang Y; Lu J; Wang M; Wang H; Chen Y; Xue D; Xie D; Li G
J Cell Mol Med; 2021 Mar; 25(5):2404-2417. PubMed ID: 33491272
[TBL] [Abstract][Full Text] [Related]
60. Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
Asari Y; Kageyama K; Sugiyama A; Kogawa H; Niioka K; Daimon M
Endocr J; 2019 Jun; 66(6):515-522. PubMed ID: 30880293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
